Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Total Voting Rights

1st Dec 2009 15:35

RNS Number : 4061D
ABCAM Plc
01 December 2009
 



For immediate release

1 December 2009

ABCAM PLC

("Abcam" or "the Company")

Total Voting Rights - Voting Rights and Capital

 

In conformity with 5.6.1 of the Disclosure and Transparency Rules, the Company notifies the market of the following:  The Company's issued share capital consists of 35,888,465 Ordinary Shares of 1p each with voting rights. The Company does not hold any shares in Treasury. The above figure of 35,888,465 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.

Date of Notification: December 2009

For further information please contact:

Abcam

+ 44 (0) 1223 696000

Jonathan Milner, Chief Executive Officer

Jeffrey Iliffe, Chief Financial Officer

Numis Securities

+ 44 (0) 20 7260 1000

Michael Meade / Nick Westlake - Nominated Adviser

James Black - Corporate Broking

Buchanan Communications

+ 44 (0) 20 7466 5000

Mark Court / Stasa Filiplic

Notes for editors:

About Abcam plc

Abcam is a producer and distributor of research-grade antibodies headquartered in CambridgeUnited Kingdom, with offices in CambridgeMassachusettsUSATokyoJapan and Hong Kong. Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company produces and distributes its own and third-party produced antibodies to academic and commercial users throughout the world. Product ordering is available through the Company's website www.abcam.com, where customers are also able to access up-to-date and detailed technical product data sheets. All the antibodies are sold under the Abcam brand name and the Company's vision is to build the world's largest online resource of high-quality and commercially viable antibodies. Abcam now has an online catalogue of over 57,000 products, most of which are antibodies, from over 250 suppliers and employs 245 staff in its four operating companies.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRUUGBPPUPBGAG

Related Shares:

ABC.L
FTSE 100 Latest
Value8,275.66
Change0.00